Amalgamated Bank’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,578
Closed -$68K 2425
2025
Q4
$68K Buy
7,578
+1,321
+21% +$8.18K ﹤0.01% 1761
2025
Q3
$23K Hold
6,257
﹤0.01% 2069
2025
Q2
$12K Hold
6,257
﹤0.01% 2367
2025
Q1
$11K Buy
6,257
+1,279
+26% +$2.91K ﹤0.01% 2331
2024
Q4
$13K Hold
4,978
﹤0.01% 2316
2024
Q3
$11K Hold
4,978
﹤0.01% 2405
2024
Q2
$15K Buy
4,978
+938
+23% +$2.86K ﹤0.01% 2239
2024
Q1
$15K Sell
4,040
-8,940
-69% -$17.2K ﹤0.01% 2265
2023
Q4
$20K Sell
12,980
-1,202
-8% -$1.55K ﹤0.01% 2651
2023
Q3
$19K Buy
14,182
+2,138
+18% +$3.56K ﹤0.01% 2680
2023
Q2
$22K Hold
12,044
﹤0.01% 2696
2023
Q1
$20K Sell
12,044
-2,696
-18% -$5.46K ﹤0.01% 2649
2022
Q4
$28K Hold
14,740
﹤0.01% 2652
2022
Q3
$33K Hold
14,740
﹤0.01% 2637
2022
Q2
$48K Sell
14,740
-10,076
-41% -$43.9K ﹤0.01% 2506
2022
Q1
$131K Sell
24,816
-2,005
-7% -$11.3K ﹤0.01% 2099
2021
Q4
$228K Buy
26,821
+15,959
+147% +$147K ﹤0.01% 1934
2021
Q3
$108K Buy
+10,862
New +$98.5K ﹤0.01% 2075

Other funds holding NUVB

Amalgamated Bank's NUVB Position: Q1 2026 in Review

Amalgamated Bank sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 7,578 shares — an estimated $68K sold.

Amalgamated Bank first reported a position in NUVB in Q3 2021 and held it in 18 quarters. The position peaked at $228K in Q4 2021. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Amalgamated Bank reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 7,578 Nuvation Bio shares in Q1 2026, an estimated $68K.
  • Amalgamated Bank first reported a position in Nuvation Bio in Q3 2021 and held it in 18 quarters.
  • Amalgamated Bank's Nuvation Bio position peaked at $228K in Q4 2021.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.